Steffen Koschmieder
Arzt
Geboren:
1971
Hat mitgewirkt an:
-
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
-
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
-
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
-
Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis